Jpmorgan Chase & Co »

Neuropace shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $117k 11k 10.31
2022-03-31 $27k 3.3k 8.11
2021-12-31 $50k 5.0k 10.10